Overview
The CRISPR industry has emerged as a revolutionary force in genetic engineering, leveraging the CRISPR-Cas9 technology developed by [[jennifer-doudna|Jennifer Doudna]] and [[emmanuelle-charpentier|Emmanuelle Charpentier]] in 2012. This powerful tool allows for precise editing of DNA, enabling advancements across fields from agriculture to medicine. As of 2023, the market for CRISPR-based products and services is projected to reach $10 billion by 2027, driven by research and development in gene therapies, diagnostics, and agricultural biotechnology.